Similarities and differences in the subcellular localization of hamartin and tuberin in the kidney

American Journal of Physiology - Renal Physiology

Volumn 278, Issue 5 47-5, 2000, Pages

  Murthy, Vanishree ^a   Haddad, Luciana A ^a   Smith, Nicole ^a   Pinney, Denise ^a   Tyszkowski, Robert ^a   Brown, Dennis ^a   Ramesh, Vijaya ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Apical membrane; Hamartomas; Intercalated cells; Tuberous sclerosis

Indexed keywords

TUBERIN;

ARTICLE; CELLULAR DISTRIBUTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; KIDNEY DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TUBEROUS SCLEROSIS;

EID: 0034034954     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.2000.278.5.f737     Document Type: Article

References (44)

1. +-ATPase. Proc Natl Acad Sci USA 86: 5429-5433, 1989.
2. Barajas L. Anatomy of the juxtaglomerular apparatus. Am J Physiol Renal Fluid Electrolyte Physiol 237: F333-F343, 1979.
3. Bernstein J and Robbins TO. Renal involvement in tuberous sclerosis. Ann NY Acad Sci 615: 36-49, 1991.
4. Breton S, Lisanti MP, Tyszkowski R, McLaughlin M, and Brown D. Basolateral distribution of caveolin-1 in the kidney. Absence from H+-ATPase-coated endocytic vesicles in intercalated cells. J Histochem Cytochem 46: 205-214, 1998.
5. Brook-Carter PT, Peral B, Ward CJ, Thompson P, Hughes J, Maheshwar MM, Nellist M, Gamble V, Harris PC, and Sampson JR. Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease - a contiguous gene syndrome. Nat Genet 8: 328-332, 1994.
6. Brown D and Breton S. Mitochondria-rich, proton-secreting epithelial cells. J Exp Biol 199: 2345-2358, 1996.
7. Brown D, Hirsch S, and Bluck S. An H+-ATPase in opposite plasma membrane domains in kidney epithelial cell subpopulations. Nature 331: 622-624, 1988.
8. Brown D, Lydon J, McLaughlin M, Stuart-Tilley A, Tyszkowski R, and Alper S. Antigen retrieval in cryostat tissue sections and cultured cells by treatment with sodium dodecyl sulfate (SDS). Histochem Cell Biol 105: 261-267, 1996.
9. Brown D and Stow JL. Protein trafficking and polarity in kidney epithelium: from cell biology to physiology. Physiol Rev 76: 245-297, 1996.
10. Carbonara C, Longa L, Grosso E, Borrone C, Garre MG, Brisigotti M, and Migone N. 9q34 loss of heterozygosity in a tuberous sclerosis astrocytoma suggests a growth suppressor-like activity also for the TSC1 gene. Hum Mol Genet 3: 1829-1832, 1994.
11. Cook JA, Oliver K, Mueller RF, and Sampson J. A cross sectional study of renal involvement in tuberous sclerosis. J Med Genet 33: 480-484, 1996.
12. Eker R. Familial renal adenomas in Wistar rats. Acta Pathol Microbiol Scand 34: 554-562, 1954.
13. The European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75: 1305-1315, 1993.
14. Ewalt DH, Sheffield E, Sparagana SP, Delgado MR, and Roach ES. Renal lesion growth in children with tuberous sclerosis complex. J Urol 160: 141-146, 1998.
15. Gomez, M. R. Tuberous Sclerosis: New York: Raven, 1988.
16. Green AJ, Johnson PH, and Yates JRW. The tuberous sclerosis gene on chromosome 9q34 acts as a growth suppressor. Hum Mol Genet 3: 1833-1834, 1994.
17. Green AJ, Smith M, and Yates JRW. Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients. Nat Genet 6: 193-196, 1994.
18. Harlow E and Lane D. Antibodies. Cold Spring Harbor, NY: Cold Spring Harbor Laboratories, 1988.
19. Henry KW, Yuan X, Koszewski NJ, Onda H, Kwiatkowski DJ, and Noonan DJ. Tuberous sclerosis gene 2 product modulates transcription mediated by steroid hormone receptor family members. J Biol Chem 273: 20535-20539, 1998.
20. Ito N and Rubin G. Gigas, a Drosophila homolog of tuberous sclerosis gene product-2, regulates the cell cycle. Cell 96: 529-539, 1999.
21. Kobayashi T, Hirayama Y, Kobayashi E, Kubo Y, and Hino O. A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer. Nat Genet 9: 218, 1995.
22. Kobayashi T, Minowa O, Kuno J, Mitani H, Hino O, and Noda T. Renal carcinogenesis, hepatic hemangiomatosis, and embryonic lethality caused by a germ-line Tsc2 mutation in mice. Cancer Res 59: 1206-1211, 1999.
23. Kobayashi T, Urakami S, Hirayama Y, Yamamaoto T, Nishizawa M, Takahara T, Kubo Y, and Hino O. Intragenic Tsc2 somatic mutations as Knudson's second hit in spontanteous and chemically induced renal carcinomas in the Eker rat model. Jpn J Cancer Res 88: 254-261, 1997.
24. Kone BC, Madsen KM, and Tisher CC. Ultrastructure of the thick ascending limb of Henle in the rat kidney. Am J Anat 171: 217-226, 1984.
25. Kurtz A and Wagner C. Cellular control of renin secretion. J Exp Biol 202: 219-225, 1999.
26. Lencer WI, Weyer P, Verkman AS, Ausiello DA, and Brown D. FITC-dextran as a probe for endosome function and localization in kidney. Am J Physiol Cell Physiol 258: C309-C317, 1990.
27. Madsen KM and Tisher CC. Structural-functional relationships along the distal nephron. Am J Physiol Renal Fluid Electrolyte Physiol 250: F1-F15, 1986.
28. Plank TL, Yeung RS, and Henske EP. Hamartin, the product of the tuberous sclerosis 1 (TSC1) gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles. Cancer Res 58: 4766-4770, 1998.
29. Plotkin MD, Kaplan MR, Verlander JW, Lee WS, Brown D, Poch E, Gullans SR, and Hebert SC. Localization of the thiazide sensitive Na-Cl cotransporter, rTSC1 in the rat kidney. Kidney Int 50: 174-183, 1996.
30. Reichard EAP, Roubidoux MA, and Dunnick NR. Renal neoplasms in patients with renal cystic diseases. Abdom Imaging 23: 237-248, 1998.
31. Roth J, Brown D, Norman AW, and Orci L. Localization of the vitamin D-dependent calcium-binding protein in mammalian kidney. Am J Physiol Renal Fluid Electrolyte Physiol 243: F243-F252, 1982.
32. Satake N, Kobayashi T, Kobayashi E, Izumi K, and Hino O. Isolation and characterization of a rat homologue of the human tuberous sclerosis 1 gene (Tsc1) and analysis of its mutations in rat renal carcinomas. Cancer Res 59: 849-855, 1999.
33. Van Slegtenhorst, M., de Hoogst R. Hermans C, Nellist M, Janssen B, Verhoef S, Lindhout D, van den Ouweland A, Halley D, Young J, Burley M, Jeremiah S, Woodward K, Nahmias J, Fox M, Ekong R, Osborne J, Wolfe J, Povey S, Snell RG, Cheadle JP, Jones AC, Tachataki M, Ravine D, Sampson JR, Reeve MP, Richardson P, Wilmer F, Munro C, Hawkins TL, Sepp T, Ali JBM, Ward S, Green AJ, Yates JRW, Kwiatkowska J, Henske EP, Short MP, Haines JH, Jozwiak S, Kwiatkowski DJ. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277: 805-808, 1997.
34. Van Slegtenhorst M, Nellist M, Nagelkerken B, Cheadle J, Snell R, vansdenOuweland A, Reuser A, Sampson J, Halley D, and vanderSluijs P. Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. Hum Mol Genet 7: 1053-1057, 1998.
35. Soucek T, Holzl G, Bernaschek G, and Hengstschlager M. A role of the tuberous sclerosis gene-2 product during neuronal differentiation. Oncogens 16: 2197-2204, 1998.
36. Soucek T, Pusch O, Weinecke R, DeClue JE, and Hengstschlager M. Role of the tuberous sclerosis gene-2 product in cell cycle control. J Biol Chem 272: 29301-29308, 1997.
37. Soucek T, Yeung RS, and Hengstschlager M. Inactivation of the cylcin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis 2 gene. Proc Natl Acad Sci 95: 15653-15658, 1998.
38. Urakami S, Tokuzen R, Tsuda H, Igawa M, and Hino O. Somatic mutation of the tuberous sclerosis (Tsc2) tumor suppressor gene in chemically induced rat renal carcinoma cell. J Urol 158: 275-278, 1997.
39. Van Baal JG, Fleury P, and Brummelkamp WH. Tuberous sclerosis and the relation with renal angiomyolipoma. A genetic study on the clinical aspects. Clin Genet 35: 167-173, 1989.
40. Wienecke R, JCM Jr, Shoarinejad F, Vass WC, Reed J, Bonifacino JS, Ruseau JH, Gunzburg JD, Yeung RS, and DeClue JE. Co-localization of the TSC2 product tuberin with its target Rap1 in the Golgi apparatus. Oncogene 13: 913-923, 1996.
41. Wienecke R, Konig A, and DeClue JE. Identification of Tuberin, the Tuberous Sclerosis-2 Product. J Biol Chem 270: 16409-16414, 1995.
42. Wienecke R, Maize JC, Reed Gunzburg JD, Yeung RS, and DeClue JE. Expression of the TSC2 product tuberin and its target Rap1 in normal human tissues. Am J Pathol 150: 43-50, 1997.
43. Xiao G-H, Shoarinejad F, Jin F, Golemis EA, and Yeung RS. The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase activating protein (GAP) in modulating endocytosis. J Biol Chem 272: 6097-6100, 1997.
44. Yeung RS, G Xiao-H, Jin F, W Lee-C, Testa JR, and Knudson AG. Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene. Proc Natl Acad Sci USA 91: 11413-11416, 1994.